Kesimpta - Yahoo Search Results

Ads
related to: Kesimpta
KESIMPTA® (ofatumumab) - FDA-Approved KESIMPTA®

www.hcp.novartis.com
Learn About KESIMPTA®. View Doctor Resources & Interactive Prescribing Info. Access PI and Start Resources for HCPs. Contact Us for Support.
FDA Approved · HCP Resources · FAQs · Download Start Form
Service catalog: KESIMPTA® Start Form, KESIMPTA® Tool Kit
About KESIMPTA®
Power with Grace.

Learn More About KESIMPTA®.

Patient Profiles
See Which Patients May Be

Ready for KESIMPTA®.

KESIMPTA® Resources
Download Tools & Forms for

Your Practice. Watch Videos.

KESIMPTA® Safety Info
See Safety Profile and Possible

Side Effects of Treatment.

KESIMPTA® Treatment
Make KESIMPTA® Your 1st

Choice. Learn More Now.

Patient Resources
Get Patient Support with the

Alongside™ KESIMPTA® Card.
KESIMPTA® (ofatumumab) - What Is KESIMPTA®?

www.kesimpta.com
See If KESIMPTA® Is Right for You. Learn About an FDA-Approved Treatment Option. Choosing a Treatment? It May Be Time to Look Into an Option Like KESIMPTA®.
Clinical Results · KESIMPTA® Autoinjector · Medication Guide
Service catalog: Alongside KESIMPTA®, Download Resources, $0 Copay
What Is KESIMPTA®?
Financial Resources
KESIMPTA® FAQs
Taking KESIMPTA®
What KESIMPTA® Can Do

- Genmab A/S (GMAB) Q4 2020 Earnings Call Transcript | The Motley Fool
  The Motley Fool· 1 day ago
  During this telephone conference you may be presented with forward-looking statements that include words such as believes, anticipates, plans or expects. Actual results may differ materially ...
- Genmab Publishes 2020 Annual Report
  StreetInsider· 17 hours ago
  Company Announcement Copenhagen, Denmark; February 23, 2021 Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2020. Below...
- FDA Nods to Novartis' Kesimpta for Relapsing Forms of MS
  Zacks via Yahoo Finance· 6 months ago
  Novartis AG NVS announced that the FDA has approved the supplemental biologics license application...
- Novartis wins FDA approval to repurpose leukaemia drug against multiple sclerosis
  Reuters via Yahoo News· 6 months ago
  Novartis on Thursday won U.S. Food and Drug Administration (FDA) approval to repurpose an...
- Edited Transcript of GMAB.CO earnings conference call or presentation 4-Nov-20 5:00pm GMT
  Thomson Reuters StreetEvents via Yahoo Finance· 4 months ago
  We have seen significant advances in our and our partners' pipelines throughout 2020, and the third quarter was no exception. On a single day in August, the U.S. FDA granted approvals to Novartis ...
- Pharma Stock Roundup: PFE, MRK Q4 Earnings, AZN, JNJ Coronavirus Vaccine Updates
  Zacks via Yahoo Finance· 3 weeks ago
  This week several large drugmakers, Pfizer PFE, Merck, MRK, AbbVie ABBV Lilly LLY, Glaxo GSK and...
- TG Therapeutics Shares Climb on Study Results
  GuruFocus.com via Yahoo Finance· 2 months ago
  After a protracted wait, TG Therapeutics Inc. (NASDAQ:TGTX) shareholders finally got rewarded for their patience last month when the stock began a rapid...
- Roche Expands Multiple Sclerosis Portfolio, Starts Studies
  Zacks via Yahoo Finance· 6 months ago
  Roche Holding AG's RHHBY subsidiary, Genentech, announced that it has initiated an innovative phase...
- Novartis' (NVS) Q3 Earnings Surpass Estimates, Sales Miss
  Zacks via Yahoo Finance· 4 months ago
  The Innovative Medicines division recorded sales of $9.8 billion, up 1% year over year. Within this...
- Roche studies Ocrevus, experimental drug in bid to defend MS franchise
  Reuters via Yahoo News· 6 months ago
  Roche is seeking to defend ground gained in treating MS since winning approval for Ocrevus three...